$21.04
+1.2%Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Advisor
Compensation
$657,668
Advisor & Co-Founder
Compensation
$526,243
Chief Financial Officer
Compensation
$825,394
Chief Technology Officer
Co-Founder & Chief Strategy Officer
Compensation
$305,469
Co-Founder, Chief Executive Officer & Chairperson
Compensation
$1,803,845
Co-founder and SVice President People & Ops
General Counsel & Corporate Secretary
Compensation
$603,941
General Counsel, Corporate Secretary & Chief Compliance Officer
Head of Investor Relations
Senior Vice President & GM Commercial Products
Senior Vice President of Commercial Operations
Compensation
$306,349
During the last 12 months, insiders have sold $9.28M worth of DOCS shares, with no buying activity reported.
0
0.00
16.1K
404.06K
-404K
-$404K
0
0.00
8.3K
279.58K
-280K
-$280K
0
0.00
46.0K
3.08M
-3.1M
-$3.08M
0
0.00
86.2K
5.52M
-5.5M
-$5.52M
No buying activity
Cabral Timothy S
Director
$3.27M
Bryson Anna
Officer: Chief Financial Officer
$2.67M
Benjamin Regina M.
Director
$1.92M
Wampler Kira Scherer
Director
$1.19M
Sitaram Siddharth
Officer: Interim Pfo And Pao
$233K
Strong bearish signal with $9.28M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
DOCS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | July 16, 2025 | August 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | July 18, 2024 | August 29, 2024 | 2024 | |
DEF 14A DEF 14A N/A | June 14, 2023 | June 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | June 15, 2022 | July 27, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.